Society Letters

Diabetes Advocacy Alliance Letter to CMS CMMI on Medicare DPP

May 13, 2020

To: Elizabeth-Ashley Matthews, MPA
Director, Division of Health Care Delivery
Prevention and Population Health Group
Center for Medicare and Medicaid Innovation

"The DAA continues to believe the expansion of the Diabetes Prevention Program (DPP) to Medicare beneficiaries has the potential to completely transform the trajectory of type 2 diabetes. However, we also believe that in the course of expanding the model, CMS made what were well-intentioned modifications to the Medicare DPP pilot. With these modifications, the Model has not achieved the increased supplier and beneficiary participation envisioned at its launch."

arrowRead the Full Summary

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!